Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sökücü (Istanbul, Turkey), C. öZdemir (Istanbul, Turkey), ö. Kahya (Istanbul, Turkey), S. Tural öNüR (Istanbul, Turkey). Eosinophilic Pneumonia Due to Sulphasalazine Use. 3026

Member's Comments

No comment yet.

Related content which might interest you: DRESS to Impress: A Case of Eosinophilic Bronchiectasis with Systemic Sequelae Source: Virtual Congress 2021 – CCC Paediatric respiratory diseases Year: 2021 Eosinophilic pneumonias Source: Eur Respir Monogr 2022; 95: 141-152 Year: 2022 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Misdiagnosis of Asthma May Delay the Post Infectious Bronchiolitis Obliterans Diagnosis Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Community-Acquired Pneumonia with Evolving Cavitation and Peripheral Eosinophilia Source: International Congress 2018 – CC8 Non-resolving pneumonia Year: 2018 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Pneumonia Source: Eur Respir Monogr 2018; 79: 87-101 Year: 2018 Pneumonia Source: ISSN=ISSN 1810-6838, ISBN=, page=195 Year: 2007 Pneumonia in women-smokers Source: Annual Congress 2007 - Smoking and the lung Year: 2007 Eosinophilic asthma Source: Eur Respir Monogr 2022; 95: 73-99 Year: 2022 Amphetamine induced eosinophilic pneumonia: A case report Source: International Congress 2014 – ILDs 6 Year: 2014 What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease? Source: Research Seminar 2007 - Severe Asthma Year: 2007 Progressive Phenotype in Chronic Hypersensitivity Pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Eosinophilic pneumonia associated with pirfenidone therapy Source: Eur Respir J 2016; 48: 1240-1242 Year: 2016 Eosinophilic COPD Source: Eur Respir Monogr 2022; 95: 100-118 Year: 2022